Palatin Technologies, Inc.
General ticker "PTN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $104.8M (TTM average)
Palatin Technologies, Inc. follows the US Stock Market performance with the rate: 8.0%.
Estimated limits based on current volatility of 6.1%: low 8.20$, high 9.26$
Factors to consider:
- Total employees count: 30 (-11.8%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Going concern doubt, Clinical trial failure, Regulatory and compliance, Commercialization challenges, Intellectual property risks
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-06-30 to 2027-06-30
- 2025-06-30 to 2026-06-30 estimated range: [6.03$, 22.62$]
- 2026-06-30 to 2027-06-30 estimated range: [4.26$, 15.26$]
Financial Metrics affecting the PTN estimates:
- Negative: with PPE of -0.2 at the end of fiscal year the price was high
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Negative: negative Net income
- Negative: Shareholder equity ratio, % of -146.22 <= 19.19
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Industry earnings per price (median), % of -18.61 <= 0
- Negative: -0.75 < Inventory ratio change, % of 0
Short-term PTN quotes
Long-term PTN plot with estimates
Financial data
| YTD | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating Revenue | $4.85MM | $4.49MM | $0.00MM |
| Operating Expenses | $37.31MM | $26.99MM | $17.46MM |
| Operating Income | $-32.46MM | $-22.50MM | $-17.46MM |
| Non-Operating Income | $0.24MM | $-7.24MM | $0.15MM |
| Interest Expense | $0.02MM | $0.02MM | $0.02MM |
| R&D Expense | $22.63MM | $22.40MM | $14.90MM |
| Income(Loss) | $-32.22MM | $-29.74MM | $-17.31MM |
| Taxes | $-4.67MM | $0.00MM | $0.00MM |
| Net Income(Loss)* | $-27.54MM | $-29.74MM | $-17.31MM |
| Stockholders Equity | $0.13MM | $-0.11MM | $-4.78MM |
| Inventory | $0.53MM | $0.00MM | $0.00MM |
| Assets | $17.94MM | $10.74MM | $3.27MM |
| Operating Cash Flow | $-29.27MM | $-31.46MM | $-21.31MM |
| Capital expenditure | $0.43MM | $0.04MM | $0.00MM |
| Investing Cash Flow | $-3.43MM | $12.45MM | $3.13MM |
| Financing Cash Flow | $10.75MM | $20.55MM | $11.21MM |
| Earnings Per Share** | $-2.53 | $-2.02 | $-32.15 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.